Impact on cardiovascular events of increasing high density lipoprotein cholesterol with and without lipid lowering drugs.
about
Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.Best practice in primary care pathology: review 7.'Real-life' reduction in cholesterol with statins, 1993 to 2002.Prospective studies on the relationship between high-density lipoprotein cholesterol and cardiovascular risk: a systematic review.Cholesteryl ester transfer-protein modulator and inhibitors and their potential for the treatment of cardiovascular diseases.
P2860
Impact on cardiovascular events of increasing high density lipoprotein cholesterol with and without lipid lowering drugs.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Impact on cardiovascular event ...... without lipid lowering drugs.
@ast
Impact on cardiovascular event ...... without lipid lowering drugs.
@en
type
label
Impact on cardiovascular event ...... without lipid lowering drugs.
@ast
Impact on cardiovascular event ...... without lipid lowering drugs.
@en
prefLabel
Impact on cardiovascular event ...... without lipid lowering drugs.
@ast
Impact on cardiovascular event ...... without lipid lowering drugs.
@en
P2860
P356
P1433
P1476
Impact on cardiovascular event ...... d without lipid lowering drugs
@en
P2093
P2860
P304
P356
10.1136/HRT.2005.068411
P407
P577
2005-10-10T00:00:00Z